IQVIA Holdings Inc. (FRA:QTS)

Germany flag Germany · Delayed Price · Currency is EUR
199.85
-1.05 (-0.52%)
At close: Jan 27, 2026
5.21%
Market Cap32.99B -4.6%
Revenue (ttm)13.55B +3.8%
Net Income1.09B -8.7%
EPS6.22 -4.2%
Shares Outn/a
PE Ratio30.17
Forward PE18.14
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume24
Open200.90
Previous Close200.90
Day's Range197.95 - 202.50
52-Week Range118.75 - 210.90
Betan/a
RSI41.20
Earnings DateFeb 5, 2026

About IQVIA Holdings

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to ... [Read more]

Industry Commercial Physical and Biological Research
CEO Ari Bousbib
Employees 91,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol QTS
Full Company Profile

Financial Performance

In 2024, IQVIA Holdings's revenue was $15.41 billion, an increase of 2.81% compared to the previous year's $14.98 billion. Earnings were $1.37 billion, an increase of 1.10%.

Financial numbers in USD Financial Statements